ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,853, issued on Sept. 16, was assigned to QILU PHARMACEUTICAL Co. LTD. (Shandong, China).

"Antibody against claudin 18A2 and use thereof" was invented by Yingying Yang (Jinan, China), Gao Li (Shandong, China), Yaning Wang (Shandong, China), Zhenming An (Shandong, China), Shuyong Zhao (Shandong, China), Yuxue Liu (Shandong, China), Shicong Liu (Shandong, China), Meijuan Zhang (Shandong, China) and Jinjin Jiang (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, a derivative comprising said antibody or antigen-binding fragment thereof, a pharmaceutical compositi...